In September, the FDA approved amebaciclib (Verzenio), the latest drug to treat endocrine resistant metastatic breast cancer (MBC). In combination with fulvestrant (Faslodex), the results of the phase III, Monarch 2 trial showed an improvement in progression free survival (PFS). All the patients in the trial were hormone receptor positive and HER2 negative, as are all the enrollees in the trials noted here.
At its annual meeting this year in June, the American Society of Clinical Oncology (ASCO) gave patient advocates an update on the TAPUR clinical trial, which is its first trial. The trial was rolled out about two years ago.
The TAPUR trial (Targeted Agent and Profiling Utilization Registry) allows us to obtain FDA-approved drugs free-of-charge by cutting out the red tape when we are no longer benefiting from any standard treatment.
Manhattan newspaper Chelsea Now recently ran a story about women who discovered they had a BRCA mutation and how they chose to take preventative action-- or what they decided to do instead. Featured in the story are SHARE's own Breast Cancer Program Director Christine Benjamin, who was diagnosed with early stage breast cancer at age 36 and later found she had an abnormal BRCA1 gene, Ovarian Helpline Coordinator Andrea Herzberg, who had been treated for late stage ovarian cancer before finding she has the BRCA2 mutation, and Deborah Polinsky, a SHARE ovarian cancer support group facilitator and patient advocate living with the BRCA1 mutation.
SHARE would like to let its constituents know about a program that offers benefits to women in New York City who may have been diagnosed with breast or ovarian cancer as a result of 9/11.
The James Zadroga 9/11 Health and Compensation Act of 2010 established a World Trade Center Health Program to provide high-quality, compassionate healthcare for survivors of 9/11 who lived, worked, or were attending school in the area.
My hope in sharing my story is to encourage women to trust their intuition and act on it when something doesn’t seem right with their body--even when symptoms might be brushed off by the medical experts, like physicians assistants & even some physicians.
SHARE and State Senator Marisol Alcantara, along with Assemblywoman Carmen De la Rosa, launched a campaign this March to raise awareness about breast cancer in Latino and African-American communities.